[Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000583:Amikacin / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002675:Child, Preschool; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007612:Kanamycin / Q000031:analogs & derivatives*; D008297:Male; D008875:Middle Aged; D012706:Serratia marcescens / Q000187:drug effects* / Q000302:isolation & purification
D007612:Kanamycin; D000583:Amikacin
Estudio clínico-bacteriológico de 20 infecciones por Serratia marcescens tratadas con amikacina.